Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform.

MLA

Bojkova, Denisa, et al. “Identification of Novel Antiviral Drug Candidates Using an Optimized SARS-CoV-2 Phenotypic Screening Platform.” IScience, vol. 26, no. 2, Feb. 2023, p. 105944. EBSCOhost, https://doi.org/10.1016/j.isci.2023.105944.

APA

Bojkova, D., Reus, P., Panosch, L., Bechtel, M., Rothenburger, T., Kandler, J. D., Pfeiffer, A., Wagner, J. U. G., Shumliakivska, M., Dimmeler, S., Olmer, R., Martin, U., Vondran, F. W. R., Toptan, T., Rothweiler, F., Zehner, R., Rabenau, H. F., Osman, K. L., Pullan, S. T., … Cinatl, J., Jr. (2023). Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform. IScience, 26(2), 105944. https://doi.org/10.1016/j.isci.2023.105944

Chicago

Bojkova, Denisa, Philipp Reus, Leona Panosch, Marco Bechtel, Tamara Rothenburger, Joshua D Kandler, Annika Pfeiffer, et al. 2023. “Identification of Novel Antiviral Drug Candidates Using an Optimized SARS-CoV-2 Phenotypic Screening Platform.” IScience 26 (2): 105944. doi:10.1016/j.isci.2023.105944.